{"SPADE_N_14014": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14014", "Peptide Name": "Ev37 (natural AMPs; scorpine-like, scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals; 3S=S, UCSS1a; recombinat rEV37)", "Source": "Venom,Euscorpiops validus", "Family": "Not found", "Gene": "Not found", "Sequence": "GLINEKKVQQYLDEKLPNGVVKGALKSLVHKAAKNQNLCAFNVDTVGMCDADCKRQGKAKGVCHGTKCKCDVELSYKK", "Sequence Length": 78, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Antiviral", "Channel inhibitors"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 8509.89, "PI": 9.22, "Hydrophobicity": -0.51, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Feng J, Yu C, Wang M, Li Z, Wu Y, Cao Z, Li W, He X, Han S. 2013", "Reference": "Protein Expr Purif. 2013 Mar;88(1):127-33. doi: 10.1016/j.pep.2012.12.004.PubMed", "Title": "Expression and characterization of a novel scorpine-like peptide Ev37, from the scorpion Euscorpiops validus"}], "Frequent Amino Acids": "KVG", "Absent Amino Acids": "OUW", "Basic Residues": 17, "Acidic Residues": 8, "Hydrophobic Residues": 27, "Polar Residues": 52, "Positive Residues": 17, "Negative Residues": 8, "Net Charge": 9, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (56.63%) toHgeScplp1 including Hge36K: 18%;  V: 10%; GRAVY: -0.51; M Wt: 8509.965; M formula: C366H617N103O110S7; mol ex coeff: 3355.Activity: rEv37 and truncated peptides showed no cytolytic activity against bacteria (B-subtilis, S-aureus or E-coli at 20 uM). Another report: rEv37 can inhibit dengue virus type 2 (DENV-2), hepatitis C virus (HCV), Zika virus (ZIKV), and herpes simplex virus type 1 (HSV-1) infections in a dose-dependent manner at IC50 2-5 uM, not toxic to host cells (Li et al., 2019).MOA:virus: direct killing and restricts viral late entry (viral membraneâ€“ endosomal membrane fusion with low pH dependence) by alkalizing acidic organelles.Recombinant production:bacteria:Escherichia coli: recombinant peptide was used to test channel-blocking activity.SAR: both the N-terminal and C-terminal domains are required for channel inhibitory activity.Toxicity: human RBC: no hemolysis at 10 uM. no effect on HEK293 cells at 5-10 uM. However, this toxin inhibited K channel Kv1.3 at 1 uM but not Kv1.1 and Kv1.2 channels (HEK293 cells).", "Similar Sequences": [{"SPADE_ID": "SPADE_N_03265", "Similarity": 0.5526315789473685, "Sequence": "GWMSEKKVQGILDKKLPEGIIRNAAKAIVHKMAKNQFGCFANVDVKGDCKRHCKAEDKEGICHGTKCKCGVPISYL"}, {"SPADE_ID": "SPADE_N_06239", "Similarity": 0.5263157894736842, "Sequence": "GWINEKKMQQKIDEKIGKNIIGGMAKAVIHKMAKNEFQCVANVDTLGNCKKHCAKTTGEKGYCHGTKCKCGIELSY"}]}}}